Economic Appraisal of the Boston Ocular Surface Prosthesis

American Journal of Ophthalmology

Volumn 148, Issue 6, 2009, Pages

  Shepard, Donald S ^a   Razavi, Moaven ^a   Stason, William B ^a   Jacobs, Deborah S ^b   Suaya, Jose A ^a   Cohen, Mark ^b   Rosenthal, Perry ^b  

^a BRANDEIS UNIVERSITY   (United States)

^b Boston Foundation for Sight   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASTIGMATISM; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CORNEAL ECTASIA; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRY EYE; EYE DISEASE; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH SERVICE; HUMAN; KERATOCONUS; LENS IMPLANT; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OCULAR SURFACE DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; QUESTIONNAIRE; SCALE UP; SCLERA LENS; TREATMENT RESPONSE; VISION; VISUAL ACUITY;

EID: 70449637256     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2009.07.012     Document Type: Article

References (26)

1. Javitt J.C., Zhou Z., and Willke R.J. Association between vision loss and higher medical care costs in Medicare beneficiaries. Ophthalmology 114 (2007) 238-245
2. US National Eye Institute. Facts about the cornea and corneal diseases. Keratoconus. Updated Nov 2008. www.nei.nih.gov/health/cornealdisease/index.asp#h Accessed: November 10, 2008
3. Jacobs D.S., and Rosenthal P. Boston scleral lens prosthetic device for treatment of ocular surface disease in chronic graft-versus-host disease. Cornea 26 (2007) 1195-1199
4. Romero-Rangel T., Stavrou P., Cotter J., Rosenthal P., Baltatzis S., and Foster C.S. Gas-permeable scleral contact lens therapy in ocular surface disease. Am J Ophthalmol 130 (2000) 25-32
5. Rosenthal P., Cotter J.M., and Baum J. Treatment of persistent corneal epithelial defect with extended wear of a fluid-ventilated gas-permeable scleral contact lens. Am J Ophthalmol 130 (2000) 33-41
6. Rosenthal P., and Croteau A. Fluid-ventilated, gas-permeable scleral contact lens is an effective option for managing severe ocular surface disease and many corneal disorders that would otherwise require penetrating keratoplasty. Eye Contact Lens 31 (2005) 130-134
7. Takahide K., Parker P.M., Wu M., et al. Use of fluid-ventilated, gas-permeable scleral lens for management of severe keratoconjunctivitis sicca secondary to chronic graft-versus-host disease. Biol Blood Marrow Transplant 13 (2007) 1016-1021
8. Stason WB, Razavi M, Jacobs DS, et al. Clinical benefits of the Boston ocular surface prosthesis. Am J Opthalmol. Forthcoming.
9. Mangione C.M., Lee P.P., Gutierrez P.R., Spritzer K., Berry S., and Hays R.D. Development of the 25-item National Eye Institute Visual Function Questionnaire (VFQ-25). Arch Ophthalmol 119 (2001) 1050-1058
10. US Securities and Exchange Commission. Bausch & Lomb Incorporated's 2006 Form 10-K (2007). http://www.sec.gov/Archives/edgar/data/10427/000001042707000105/bol10k2006.htm Accessed: June 25, 2009
11. DeNavas-Walt C., Proctor B.D., and Smith J.C. Income, poverty, and health insurance coverage in the United States: 2007. Current population reports (P60-235) (2007). http://www.census.gov/prod/2008pubs/p60-235.pdf Accessed: July 7, 2009
12. IRS Standard Mileage Rates. 2006 mileage rates. About.com. Tax planning: US. http://taxes.about.com/od/2006taxes/qt/IRSMileageRate.htm Accessed: May 1, 2009
13. US General Services Administration. Domestic per diem rates, 2006, Massachusetts. http://www.gsa.gov/Portal/gsa/ep/contentView.do?queryYear=2006&contentType=GSA_BASIC&contentId=17943&queryState=Massachusetts&noc=T Accessed: May 1, 2009
14. Massof R.W., and Ahmadian L. What do different visual function questionnaires measure?. Ophthalmic Epidemiol 14 (2007) 198-204
15. Brown G.C. Vision and quality-of-life. Trans Am Ophthalmol Soc 97 (1999) 473-511
16. Gold M., Siegel J., Russell L., and Weinstein M. Cost-effectiveness analysis in health and medicine (1966), Oxford University Press, New York, New York
17. Steinberg E.P., Tielsch J.M., Schein O.D., et al. The VF-14. An index of functional impairment in patients with cataract. Arch Ophthalmol 112 (1994) 630-638
18. Boisjoly H., Gresset J., Charest M., et al. The VF-14 index of visual function in recipients of a corneal graft: a 2-year follow-up study. Am J Ophthalmol 134 (2002) 166-171
19. Jacobson G., Frick K., and Massof R. Impact of low vision and chronic ophthalmic conditions on absenteeism and lost work productivity 2005; 22: abstract no. 4117. http://gateway.nlm.nih.gov/MeetingAbstracts/ma?f=103623580.html Accessed: July 6, 2009
20. US Food and Drug Administration. Federal Register Vol. 64 No. 221. Food labeling: Trans fatty acids in nutrition labeling, nutrient content claims, and health claims; proposed rule (November 1999) 62. 772 http://vm.cfsan.fda.gov/∼lrd/fr991117.html Accessed: March 5, 2009
21. Cutler D.M., and Richardson E. Measuring the health of the U.S. population (1997). http://ideas.repec.org/a/bin/bpeajo/v28y1997i1997-1p217-282.html Accessed: March 5, 2009
22. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. (1988), Lawrence Erlbaum Associates, Hillsdale, New Jersey
23. Webster Jr. B.H., and Bishaw A. Income, earnings, and poverty data from the 2006 American Community Survey. ACS-08 (2007). http://www.census.gov/prod/2007pubs/acs-08.pdf Accessed: March 5, 2009
24. Zarkin G.A., Dean N., Mauskopf A., and Williams R. Potential health benefits of nutrition label changes. Am J Public Health 83 (1993) 717-724
25. Roe R.H., Lass J.H., Brown G.C., and Brown M.M. The value-based medicine comparative effectiveness and cost-effectiveness of penetrating keratoplasty for keratoconus. Cornea 27 (2008) 1001-1007
26. Pramanik S., Musch D.C., Sutphin J.E., and Farjo A.A. Extended long-term outcomes of penetrating keratoplasty for keratoconus. Ophthalmology 113 (2006) 1633-1638